Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Evofem Biosciences ( (EVFM) ).
Evofem Biosciences, Inc. reported that it periodically shares slide presentations with the investment community at industry and other conferences to provide updates and summaries of its business. The company has made its current corporate slide deck available to investors by posting it on the investor section of its website and noted that the materials, furnished via a recent regulatory filing, are not deemed filed for liability purposes and may be updated at the company’s discretion.
The most recent analyst rating on (EVFM) stock is a Sell with a $0.01 price target. To see the full list of analyst forecasts on Evofem Biosciences stock, see the EVFM Stock Forecast page.
Spark’s Take on EVFM Stock
According to Spark, TipRanks’ AI Analyst, EVFM is a Neutral.
Evofem Biosciences faces significant financial challenges, with high leverage and negative equity posing risks to financial stability. Technical indicators show weak momentum, and the negative P/E ratio reflects ongoing losses. The absence of earnings call data and corporate events limits additional insights.
To see Spark’s full report on EVFM stock, click here.
More about Evofem Biosciences
Average Trading Volume: 493,614
Technical Sentiment Signal: Sell
Current Market Cap: $1.17M
For detailed information about EVFM stock, go to TipRanks’ Stock Analysis page.